Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FITS: Intercept Fibrinogen Complex vs Cryoprecipitate in Liver Transplant
NCT07265843Phase 4Recruiting
- Sponsor
- THOR Network
- Start
- May 2026
- Primary completion
- Mar 2028
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
A Phase 4 trial of INTERCEPT Fibrinogen Complex in hypofibrinogenemia, hemorrhage, sponsored by THOR Network. Started May 2026; status: recruiting.
02
Drugs
INTERCEPT Fibrinogen Complex
03
Conditions
hypofibrinogenemiahemorrhage
Beyond the preview
Go deeper on NCT07265843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07265843.